ZeroStack Corp.

ZeroStack Corp. shareholders approved an amendment to the 2022 Incentive Compensation Plan, significantly increasing common shares and incentive stock options available for issuance. They also approved the issuance of 9,104,614 common shares for the acquisition of Texas Blocker Corp. Additionally, shareholders ratified stock option grants for executives, a bylaws amendment for staggered board terms, and reappointed Davidson & Company LLP as auditors.

ZeroStack Corp. granted a total of 1,250,000 stock options to its CEO, CFO, and Executive Chairman on May 5, 2026. The options are exercisable at $5.10 per share and have a 10-year term. Vesting is tied to the company's common share volume weighted average price (VWAP), with 20% vesting at each of five VWAP thresholds ranging from $7.65 to $17.85. The grants are subject to shareholder approval at the upcoming annual and special meeting of shareholders to be held on or about July 13, 2026.

ZeroStack Corp. reported a net loss of $36.7 million for Q1 2026, a significant increase from $0.76 million in Q1 2025, primarily driven by a $60.7 million loss from changes in the fair value of digital assets. The company's total assets decreased by 65% to $45.19 million from $130.24 million at year-end 2025. ZeroStack is undergoing a strategic shift, focusing on AI infrastructure through investments in 0G Tokens and its global pharmaceutical distribution business, Phatebo GmbH, following the divestment of its cannabis-related businesses in Q3 2025. The company also plans an Exchange with Texas Blocker Corp. and a redomicile to Texas, subject to shareholder approvals. Management believes existing cash and staking rewards are sufficient for going concern for at least one year.